THE LIBRARY
Compound Library
Every compound in The Vial Files — search, filter and open a full protocol file.
78 compound files
Mechanisms, findings & studies
Research in context
Experimental ≠ established
Evidence, not guesswork
Sources & safety limitations
Precision tools
Peptide & TDEE calculators
THE RESEARCH INDEX
Peptide protocol library78 files
Orbitrex catalog · October 18, 2026
78 files · All categories
Source-linked research5-amino-1mq
Non-peptide research compound. No established human self-dosing protocol.
Adamax
Experimental modified peptide; human safety and dosing are not established.
AHK-Cu
Not carried by OrbitrexCopper-binding tripeptide (Ala-His-Lys) studied for hair follicle stimulation, angiogenesis, and scalp health.
AOD-9604
Growth hormone fragment investigated in metabolic research.
ARA-290
Erythropoietin-derived peptide investigated in tissue-protection research.
BPC-157
Pentadecapeptide derived from a gastric protein. Investigated for tendon, ligament, and gut healing via angiogenesis and growth factor modulation.
Buffered NAD+
Non-peptide research compound. No established human self-dosing protocol.
BURN
Research blend of SLU-PP-332, MOTS-C, and AOD-9604, offered as drops. This composition does not establish combined efficacy or safety; no blend-specific clinical effects are asserted.
Cagrilintide
Long-acting amylin analog investigated for weight management.
Cartalax
Short peptide studied in cell and tissue research.
Cartalax/TB4/BPC Blend
Not carried by OrbitrexResearch blend combining the cartilage bioregulator Cartalax with TB-500 and BPC-157. Investigated for joint, tendon, and soft-tissue repair support.
Cerebrolysin
Not carried by OrbitrexPorcine brain-derived peptide preparation with neurotrophic and neuroprotective properties. Studied for stroke recovery, cognitive impairment, and traumatic brain injury.
Cerebroprotein Hydrolysate
Not carried by OrbitrexPorcine brain-derived peptide mixture similar in composition to Cerebrolysin. Studied for neuroprotection, stroke recovery, and cognitive decline.
CJC-1295
Not carried by OrbitrexGHRH analog that increases growth hormone and IGF-1. Often paired with a GHRP such as Ipamorelin for synergistic pulses.
CJC-1295 (no DAC) + IPA
Growth-hormone signaling peptide blend. Combination dosing is not clinically established.
Cortagen
Short peptide investigated in neurological research.
Dihexa
Not carried by OrbitrexPeptide analog of angiotensin IV with potent neurotrophic activity. Promotes synaptogenesis and is investigated for memory and cognitive impairment.
DSIP
Delta sleep-inducing peptide investigated in sleep-related research.
Eloralintide
Not carried by OrbitrexInvestigational, long-acting selective amylin-receptor agonist in clinical development for obesity. Clinical research examines weight management and metabolic outcomes; it is not an approved treatment.
Epithalon
Experimental tetrapeptide explored in aging and cellular research.
Follistatin 344
Not carried by OrbitrexMyostatin-binding protein that promotes muscle hypertrophy by inhibiting myostatin and activin signaling.
FOXO4-DRI
Experimental senolytic peptide; preclinical findings do not establish human dosing.
GHK-Cu
Copper-binding tripeptide with wound-healing, anti-inflammatory, and skin remodeling activity. Widely used in cosmetic formulations.
GHK-Cu/KPV Blend
Not carried by OrbitrexResearch blend combining GHK-Cu with the anti-inflammatory tripeptide KPV. Studied for skin remodeling, immune modulation, and tissue repair.
GHRP-2
Not carried by OrbitrexSecond-generation growth hormone releasing peptide with potent GH-releasing activity via the ghrelin receptor.
GHRP-6
Not carried by OrbitrexHexapeptide GHRP that stimulates GH secretion and appetite via the ghrelin receptor.
GLOW 70
Multi-peptide research blend. Verify each constituent against batch documentation.
Glutathione
Tripeptide antioxidant involved in cellular redox regulation.
HCG
Not carried by OrbitrexGlycoprotein hormone mimicking LH to stimulate endogenous testosterone production and testicular function.
Hexarelin
Not carried by OrbitrexPotent synthetic GHRP that stimulates strong growth hormone release. Also studied for cardioprotective effects.
HGH Fragment 176-191
Not carried by OrbitrexC-terminal fragment of human growth hormone studied for targeted lipolysis without affecting IGF-1 or blood glucose.
HMG
Not carried by OrbitrexPurified gonadotropin containing FSH and LH activity. Used in fertility research to stimulate follicular development and spermatogenesis.
Humanin
Not carried by OrbitrexMitochondrial-derived peptide with cytoprotective effects. Studied for neuroprotection, insulin sensitivity, and healthy aging.
IGF-1 DES
Not carried by OrbitrexTruncated IGF-1 analog (missing first 3 amino acids) with high local potency and short half-life; studied for site-specific hypertrophy.
IGF-1 LR3
Not carried by OrbitrexLong R3 analog of Insulin-like Growth Factor 1 with prolonged half-life and reduced binding to IGFBPs.
Ipamorelin
Growth hormone secretagogue investigated in endocrine research.
Kisspeptin
Peptide involved in reproductive hormone signaling.
KLOW
Multi-peptide blend; combined safety and human dosing are not established.
KPV
Tripeptide investigated in inflammation-related preclinical research.
Livagen
Not carried by OrbitrexKhavinson tripeptide bioregulator (Lys-Glu-Asp) studied for liver tissue repair, hepatocyte function, and metabolic detoxification support.
LL-37
Antimicrobial peptide with immune-signaling activity and important safety uncertainties.
Mazdutide
Not carried by OrbitrexDual GLP-1 / glucagon receptor agonist approved in China in 2025 (Innovent) for obesity, with research in type 2 diabetes and hepatic fat reduction. It is not FDA-approved.
Melanotan I
Melanocortin agonist associated with afamelanotide research. The community identifies MT-1 as Melanotan I; research powder is not equivalent to a licensed implant.
Melanotan II
Experimental melanocortin agonist. No established safe self-use regimen.
MGF
Not carried by OrbitrexSplice variant of IGF-1 released by mechanically loaded muscle. Studied for satellite cell activation and localized muscle repair.
MOTS-C
Mitochondrial-derived peptide investigated in cellular metabolism.
N-Acetyl Selank Amidate
Modified Selank analog. Evidence for Selank cannot establish dosing for this derivative.
N-Acetyl Semax Amidate
Modified Semax analog. Parent-compound protocols are not transferable.
NAD+
Non-peptide research compound. No established human self-dosing protocol.
Orbitzen 40
Recovery blend of BPC-157, TB-500 and KPV.
Ovagen
Not carried by OrbitrexKhavinson tripeptide bioregulator (Glu-Asp-Leu) studied for retinal and visual system tissue support, photoreceptor function, and neuroprotection of the eye.
Oxytocin
Peptide hormone with prescription medical uses requiring indication-specific supervision.
P-21
Not carried by OrbitrexPeptide fragment of CNTF designed to promote neurogenesis without CNTF's side effects. Studied for memory and neurodegeneration models.
Pancragen
Not carried by OrbitrexKhavinson tripeptide bioregulator (Lys-Glu-Asp) studied for pancreatic tissue function, islet cell support, and glucose metabolism regulation.
PE-22-28
Experimental peptide explored in neurobiological research.
PEG-MGF
Not carried by OrbitrexPEGylated form of MGF with extended half-life for systemic delivery. Studied for muscle repair and hypertrophy.
Pinealon
Short peptide investigated in cellular and neurological research.
Prostamax
Not carried by OrbitrexKhavinson bioregulator peptide (Lys-Glu) studied for prostate tissue function, epithelial integrity, and male reproductive health support.
PT-141
Bremelanotide: prescription-label information exists for Vyleesi, not for research vials.
Retatrutide
Investigational GIP, GLP-1 and glucagon receptor agonist studied for obesity.
Selank
Synthetic peptide investigated in anxiety-related research.
Selank/Semax Blend
Not carried by OrbitrexResearch blend combining the anxiolytic peptide Selank with the cognitive peptide Semax. Investigated for combined mood, focus, and neuroprotection support.
Semaglutide
GLP-1 receptor agonist studied for weight management and type 2 diabetes.
Semax
Synthetic peptide studied in neurological research; regulatory status varies by country.
Sermorelin
Growth hormone-releasing hormone analog with endocrine research history.
SLU-PP-332
Non-peptide research compound. No established human self-dosing protocol.
SNAP-8
Not carried by OrbitrexOctapeptide topical analog of SNAP-25 that modulates SNARE-complex signaling to reduce expression lines. Common cosmetic ingredient.
SomatoPulse
1:1 Ipamorelin + Tesamorelin growth hormone blend.
SS-31
Elamipretide, a mitochondria-targeting peptide studied in mitochondrial disorders.
Survodutide
Investigational glucagon / GLP-1 receptor agonist studied in clinical trials.
TB-500
Thymosin-related research peptide; full-length thymosin β4 findings may not apply.
Tesamorelin
Growth hormone-releasing factor analog studied for excess abdominal fat in HIV-associated lipodystrophy.
Thymalin
Not carried by OrbitrexKhavinson bioregulator polypeptide complex derived from thymic tissue. Studied for T-cell function, immune restoration, and geroprotective effects in aging populations.
Thymosin Alpha-1
Immune-modulating peptide with jurisdiction-specific clinical research and use.
Tirzepatide
Dual GIP / GLP-1 receptor agonist studied for weight management and type 2 diabetes.
Vilon
Experimental short peptide investigated in cellular research.
VIP
Vasoactive intestinal peptide involved in vascular and immune signaling.
Wolverine
Research peptide blend. Component studies do not establish a safe combined regimen.
THE NUMBERS MATTER
Less guesswork. More clarity.
Concentration calculations and daily energy estimates.